DEH-113(DEH-113) - 在研适应症：原发性痛经_专利_临床

概要

基本信息

药物类型

小分子化药

别名

靶点-

作用机制-

治疗领域

神经系统疾病

在研适应症

原发性痛经

非在研适应症-

原研机构

EMS Sigma Pharma Ltda.

在研机构

EMS SA (Brazil)

非在研机构-

最高研发阶段临床3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 DEH-113 相关的临床试验

NCT06268054 / Not yet recruiting临床3期

A National, Multicenter, Randomized, Double-blind, Phase III, Crossover Clinical Trial to Assess the Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.

The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.

开始日期2025-02-01

申办/合作机构

EMS SA (Brazil)

NCT06555549 / Not yet recruitingN/A

A National, Multicenter, Randomized, Double-blind, Single-dose, Crossover Clinical Trial to Preliminary Evaluate the Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramps Pain Associated With Primary Dysmenorrhea

This study aims to evaluate the preliminary efficacy and safety of DEH113 in the Treatment of Menstrual Cramps Pain Associated with Primary Dysmenorrhea.

开始日期2024-09-01

申办/合作机构

EMS SA (Brazil)

100 项与 DEH-113 相关的临床结果

登录后查看更多信息

100 项与 DEH-113 相关的转化医学

登录后查看更多信息

100 项与 DEH-113 相关的专利（医药）

登录后查看更多信息

100 项与 DEH-113 相关的药物交易

登录后查看更多信息